Abstract:RATIONALE: IL-25 (IL-17E) is a Th2 type cytokine best described as a potentiator of Th2 memory responses. Reports of expression of its receptor, IL-25R, on airways structural cells suggest a wider role for IL-25 in remodelling. We hypothesized that IL-25 stimulates local angiogenesis in the asthmatic bronchial mucosa.METHODS: Immunoreactive IL-25+, IL-25R+ and CD31+ (endothelial) cells in sections of bronchial biopsies from asthmatics and controls were detected by immunohistochemistry. The effect of IL-25 on angiogenesis was examined using an in vitro assay. Real-time PCR was employed to detect expression of IL-25R and VEGF mRNA in cultured human umbilical vascular endothelial cells (HUVEC) and a WST-8 assay kit was used to measure effect of IL-25 on HUVEC proliferation.RESULTS: Immunostaining showed that IL-25+, IL-25R+ and CD31+/IL-25R+ cells were significantly elevated in the bronchial mucosa of asthmatics compared with controls (p<0.003). In the asthmatics, the numbers of IL-25+ cells correlated inversely with FEV1 (r=-0.639, p=0.01). In vitro, HUVEC constitutively expressed IL-25R which was further upregulated by TNF-α. IL-25 and TNF-α also increased expression of VEGF and VEGF receptors. IL-25 increased HUVEC proliferation and the numbers, lengths and areas of microvessel structures in a concentration dependent manner in vitro. VEGF blockade, the PI3K specific inhibitor LY294002 and the MEK 1/2 specific inhibitor U0126 all markedly attenuated IL-25-induced angiogenesis, while the inhibitors also reduced IL-25-induced proliferation and VEGF expression.CONCLUSION: IL-25 is elevated in asthma which might contribute to angiogenesis by increasing endothelial cell VEGF/VEGFR expression through PI3K/Akt and Erk/MAPK pathways. RATIONALE: IL-25 (IL-17E) is a Th2 type cytokine best described as a potentiator of Th2 memory responses. Reports of expression of its receptor, IL-25R, on airways structural cells suggest a wider role for IL-25 in remodelling. We hypothesized that IL-25 stimulates local angiogenesis in the asthmatic bronchial mucosa. METHODS: Immunoreactive IL-25+, IL-25R+ and CD31+ (endothelial) cells in sections of bronchial biopsies from asthmatics and controls were detected by immunohistochemistry. The effect of IL-25 on angiogenesis was examined using an in vitro assay. Real-time PCR was employed to detect expression of IL-25R and VEGF mRNA in cultured human umbilical vascular endothelial cells (HUVEC) and a WST-8 assay kit was used to measure effect of IL-25 on HUVEC proliferation. RESULTS: Immunostaining showed that IL-25+, IL-25R+ and CD31+/IL-25R+ cells were significantly elevated in the bronchial mucosa of asthmatics compared with controls (p<0.003). In the asthmatics, the numbers of IL-25+ cells correlated inversely with FEV1 (r=-0.639, p=0.01). In vitro, HUVEC constitutively expressed IL-25R which was further upregulated by TNF-α. IL-25 and TNF-α also increased expression of VEGF and VEGF receptors. IL-25 increased HUVEC proliferation and the numbers, lengths and areas of microvessel structures in a concentration dependent manner in vitro. VEGF blockade, the PI3K specific inhibitor LY294002 and the MEK 1/2 specific inhibitor U0126 all markedly attenuated IL-25-induced angiogenesis, while the inhibitors also reduced IL-25-induced proliferation and VEGF expression. CONCLUSION: IL-25 is elevated in asthma which might contribute to angiogenesis by increasing endothelial cell VEGF/VEGFR expression through PI3K/Akt and Erk/MAPK pathways.

A three-dimensional in vitro model of angiogenesis in the airway mucosa

Angiogenesis in bronchial asthma

Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma

Unique Mechanisms of Connective Tissue Growth Factor Regulation in Airway Smooth Muscle in Asthma: Relationship with Airway Remodelling

A novel in vitro tubular model to recapitulate features of distal airways: the bronchioid

Brs-3 Activation Transforms the Effect of Human Bronchial Epithelial Cells from Pge2 Mediated Inhibition to Tgf-Beta 1 Dependent Promotion on Proliferation and Collagen Synthesis of Lung Fibroblasts

Air-liquid interface (ALI) model of human bronchial epithelia cells for the investigation of asthma exacerbations

Airway Basal Cell Vascular Endothelial Growth Factor-Mediated Cross-Talk Regulates Endothelial Cell-Dependent Growth Support of Human Airway Basal Cells

HB-EGF–Promoted Airway Smooth Muscle Cells and Their Progenitor Migration Contribute to Airway Smooth Muscle Remodeling in Asthmatic Mouse

Airway Fibroblasts Isolated from Mouse Model of Allergic Asthma Display Distinct Cellular and Phenotypic Characteristics As Compared to Normal Fibroblasts

TGF-β1 Induces Human Bronchial Epithelial Cell-to-Mesenchymal Transition in Vitro

ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway

A 3D Epithelial-Mesenchymal Co-Culture Model of the Airway Wall Using Native Lung Extracellular Matrix

Comparison of 3D airway models for the assessment of fibrogenic chemicals

Angiogenesis In Asthma: A Novel Potential Role For Il-25

A Modular Human Airway Lung‐Chip for Studying the Effect of Breathing‐Mechanics on Airway Epithelial Cell Biology

Development of a bronchial epithelium model innervated by sensory neurons from human induced pluripotent stem cells

High-throughput Bronchus-on-a-Chip system for modeling the human bronchus

Airway remodelling in asthma and the epithelium: on the edge of a new era

A novel approach to investigate severe asthma and COPD: the 3d ex vivo respiratory mucosa model